GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
GlycoMimetics reports 2023 executive compensation
By ExecPay News
Published: April 1, 2024
GlycoMimetics reported fiscal year 2023 executive compensation information on April 1, 2024.
In 2023, three executives at GlycoMimetics received on average a compensation package of $1.6M, a 56% increase compared to previous year.
Harout Semerjian, Chief Executive Officer, received $2.4M in total, which increased by 67% compared to 2022. 53% of Semerjian's compensation, or $1.3M, was in option awards. Semerjian also received $100K in bonus, $377K in non-equity incentive plan, $638K in salary, as well as $11K in other compensation.
Brian M. Hahn, Chief Financial Officer, received a compensation package of $1.3M, which increased by 42% compared to previous year. 37% of the compensation package, or $478K, was in option awards.
Edwin Rock, Chief Medical Officer, earned $1.2M in 2023.